Garvan Institute - Transient production of SARS-COV-2 antigen (spike protein)

Project Member(s): Ralph, P.

Funding or Partner Organisation: Garvan Institute of Medical Research
Garvan Institute of Medical Research

Start year: 2020

Summary: To express SARS-COV-2 spike proteins transiently in HEK-293 cells using Expi293 expression platform from Thermo

FOR Codes: Human Pharmaceutical Treatments (e.g. Antibiotics), Medical Molecular Engineering of Nucleic Acids and Proteins, Human pharmaceutical treatments

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.